David Levine (@dlloydlevine) is co-chairman of Science Writers in New York and a member the National Association of Science Writers and the Association of Health Care Journalists. He writes for The New York Times, Reuters Health, Scientific American Mind, Nature Medicine, the Los Angeles Times, Nautilus, and the Smithsonian.
Latest by David Levine
Lower levels of vitamin D are linked to an increased risk of aggressive prostate cancer. Learn what that could mean for your prostate health.
Should men with intermediate-risk prostate cancer be offered active surveillance as a treatment? Learn what new research suggests.
If you're a man with low-risk prostate cancer, consider this study that found a significant cost variation among competing prostate treatments.